Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEV of 0.5% Ropivacaine in SASIS-FICB
NCT05012137Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2021
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Single-blind, single-arm trial of ropivacaine in surgical anesthesia, sponsored by Peking Union Medical College Hospital. Primary endpoint: Minimum Effective Volume in 90% of patients up to 6 months. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
surgical anesthesia
Beyond the preview
Go deeper on NCT05012137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05012137.